Rep. Josh Gottheimer Purchases Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Representative Josh Gottheimer (D-New Jersey) recently bought shares of U.S. Physical Therapy, Inc. (NYSE:USPH). In a filing disclosed on November 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in U.S. Physical Therapy stock on October 17th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.

Representative Josh Gottheimer also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Texas Capital Bancshares (NASDAQ:TCBI) on 10/31/2024.
• Sold $1,001 – $15,000 in shares of ITT (NYSE:ITT) on 10/31/2024.
• Sold $1,001 – $15,000 in shares of Stifel Financial (NYSE:SF) on 10/31/2024.
• Sold $1,001 – $15,000 in shares of ICU Medical (NASDAQ:ICUI) on 10/31/2024.
• Sold $1,001 – $15,000 in shares of AppFolio (NASDAQ:APPF) on 10/31/2024.
• Purchased $1,001 – $15,000 in shares of Gates Industrial (NYSE:GTES) on 10/31/2024.
• Purchased $1,001 – $15,000 in shares of Techtronic Industries (OTCMKTS:TTNDY) on 10/29/2024.
• Purchased $1,001 – $15,000 in shares of Techtronic Industries (OTCMKTS:TTNDY) on 10/28/2024.
• Purchased $1,001 – $15,000 in shares of Disco (OTCMKTS:DSCSY) on 10/28/2024.
• Purchased $1,001 – $15,000 in shares of Enerpac Tool Group (NYSE:EPAC) on 10/25/2024.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $95.30 on Friday. The firm has a market capitalization of $1.44 billion, a PE ratio of 89.91, a price-to-earnings-growth ratio of 3.93 and a beta of 1.38. The business’s fifty day moving average price is $83.43 and its 200 day moving average price is $91.56. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 1.88. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $0.76 EPS. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.85%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 166.04%.

Institutional Investors Weigh In On U.S. Physical Therapy

Several hedge funds have recently made changes to their positions in the business. Precision Wealth Strategies LLC boosted its stake in shares of U.S. Physical Therapy by 5.1% during the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock worth $239,000 after buying an additional 137 shares during the period. Texas Permanent School Fund Corp lifted its position in U.S. Physical Therapy by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock valued at $1,480,000 after purchasing an additional 170 shares during the period. First Horizon Advisors Inc. lifted its position in U.S. Physical Therapy by 18.6% in the second quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock valued at $110,000 after purchasing an additional 186 shares during the period. Louisiana State Employees Retirement System lifted its position in U.S. Physical Therapy by 2.7% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $702,000 after purchasing an additional 200 shares during the period. Finally, Martin Capital Advisors LLP lifted its position in U.S. Physical Therapy by 1.6% in the third quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock valued at $1,112,000 after purchasing an additional 201 shares during the period.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, Director Kathleen A. Gilmartin bought 2,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was bought at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several brokerages have issued reports on USPH. Bank of America reaffirmed a “neutral” rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Barrington Research reaffirmed an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2025. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2024 election. Gottheimer was first elected to the House in 2016. Prior to his election, Gottheimer worked for Microsoft, the Federal Communications Commission, and for the administration of President Bill Clinton (D). Click here for more information about Gottheimer’s career. Gottheimer serves on the House Financial Services Committee, where is a member of three subcommittees. For more on Gottheimer’s committee assignments, click here. Gottheimer became a co-chair of the Problem Solvers Caucus in February 2017. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.